FindTrial
Sign In

A feasibility study of postroperative adjuvant chemotherapy using platinum-based chemotherapy followed by maintenance TS-1 for completely resected pathologic stage II-IIIA non-small cell lung cancer with a biomarker study of circulating tumor cell

A feasibility study of postroperative adjuvant chemotherapy using platinum-based chemotherapy followed by maintenance TS-1 for completely resected pathologic stage II-IIIA non-small cell lung cancer with a biomarker study of circulating tumor cell - Feasibility study of postoperative maintenance TS-1 chemotherapy and a biomarker study of CTC in NSCLC

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000002592
Enrollment
40
Registered
2009-10-07
Start date
2009-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Completely resected pathologic stage II-IIIA non-small cell lung cancer

Interventions

Maintenance TS-1 administration following platinum-based chemotherapy

Sponsors

DEPARTMENT OF THORACIC SURGERY, HYOGO COLLEGE OF MEDICINE
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Pathologically-proven non-small cell lung cancer 2) Completery resected pathologic stage II-IIIA (UICC-7th) 3) No previous treatment for lung cancer 4) Performance status 0-1 (ECOG) 5) Good major organ function 6) age, 20years or higher 7) Written informed consent

Exclusion criteria

Exclusion criteria: Active other malignant disease

Design outcomes

Primary

MeasureTime frame
Compliance of maintenance TS-1 administration following platinum-based chemotherapy in postoperative adjuvant setting—

Secondary

MeasureTime frame
Safety profile, Didsease-free survival; Overall survival; CTC-count in correlation with clinical outcome—

Countries

Japan

Contacts

Public ContactFUMIHIRO TANAKA

HYOGO COLLEGE OF MEDICINE THORACIC SURGERY

ftanaka@hyo-med.ac.jp

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026